Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20056900 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase II Study to Evaluate the Efficacy of AMG 317
Condition: Asthma
Interventions: Biological: AMG 317 75 mg;   Biological: AMG 317 150 mg;   Biological: AMG 317 300 mg;   Biological: Placebo

Indicates status has not been verified in more than two years